James G. Wolf files SEC Form 4 disclosures for ENZO BIOCHEM INC. They have made 3 open-market trades across 1 company since 2022, most recently 2023-02-13.
CIK 0001419248
3 open-market purchases totalling $79K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ENZ | 4,100,000 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2023-02-13 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.